Tanshinone IIA induces growth inhibition and apoptosis in gastric cancer in vitro and in vivo

Oncology Reports

Volumn 27, Issue 2, 2012, Pages 523-528

  Chen, Jian ^a   Shi, Dong Yun ^b   Liu, Shan Lin ^b   Zhong, Liang ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

G2 M phase arrest; Gastric cancer; Intrinsic apoptosis; Tanshinone IIA

Indexed keywords

TANSHINONE IIA; ABIETANE DERIVATIVE; ANTINEOPLASTIC AGENT; TANSHINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; IN VITRO STUDY; IN VIVO STUDY; M PHASE CELL CYCLE CHECKPOINT; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOMACH CANCER; ANIMAL; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; DISEASE MODEL; DRUG SCREENING; HUMAN; NUDE MOUSE; STOMACH TUMOR; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DITERPENES, ABIETANE; HUMANS; MALE; MICE; MICE, NUDE; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84855752580     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1524     Document Type: Article

References (24)

1. Saif MW, Makrilia N, Zalonis A, Merikas M and Syrigos K: Gastric cancer in the elderly: an overview. Eur J Surg Oncol 36: 709-717, 2010.
2. Bittoni A, Maccaroni E, Scartozzi M, Berardi R and Cascinu S: Chemotherapy for locally advanced and metastatic gastric cancer: state of the art and future perspectives. Eur Rev Med Pharmacol Sci 14: 309-314, 2010.
3. Roukos DH: Current status and future perspectives in gastric cancer management. Cancer Treat Rev 26: 243-255, 2000.
4. Groth S, Nielsen H, Sorensen JB, Christensen AB, Pedersen AG and Rorth M: Acute and long-term nephrotoxicity of cis-platinum in man. Cancer Chemother Pharmacol 17: 191-196, 1986. (Pubitemid 16082023)
5. Stewart DJ: Mechanisms of resistance to cisplatin and carboplatin. Crit Rev Oncol Hematol 63: 12-31, 2007.
6. Efferth T, Dunstan H, Sauerbrey A, Miyachi H and Chitambar CR: The anti-malarial artesunate is also active against cancer. Int J Oncol 18: 767-773, 2001.
7. Gutheil WG, Reed G, Ray A and Dhar A: Crocetin: an agent derived from saffron for prevention and therapy for cancer. Curr Pharm Biotechnol: April 5, 2011 (Epub ahead of print).
8. Gao H, Lamusta J, Zhang WF, Salmonsen R, Liu Y, O'Connell E, Evans JE, Burstein S and Chen JJ: Tumor cell selective cytotoxicity and apoptosis induction by an herbal preparation from Brucea javanica. N A J Med Sci 4: 62-66, 2011.
9. Chiu TL and Su CC: Tanshinone IIA induces apoptosis in human lung cancer A549 cells through the induction of reactive oxygen species and decreasing the mitochondrial membrane potential. Int J Mol Med 25: 231-236, 2010.
10. Dong Y, Morris-Natschke SL and Lee KH: Biosynthesis, total syntheses, and antitumor activity of tanshinones and their analogs as potential therapeutic agents. Nat Prod Rep 28: 529-542, 2011.
11. Wang X, Morris-Natschke SL and Lee KH: New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev 27: 133-148, 2007. (Pubitemid 44975189)
12. Yoon Y, Kim YO, Jeon WK, Park HJ and Sung HJ: Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line. J Ethnopharmacol 68: 121-127, 1999. (Pubitemid 29502468)
13. Wang X, Wei Y, Yuan S, Liu G, Lu Y, Zhang J and Wang W: Potential anticancer activity of tanshinone IIA against human breast cancer. Int J Cancer 116: 799-807, 2005. (Pubitemid 41099713)
14. Yuxian X, Feng T, Ren L and Zhengcai L: Tanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo. Tumori 95: 789-795, 2009.
15. Tang C, Xue HL, Huang HB and Wang XG: Tanshinone IIA inhibits constitutive STAT3 activation, suppresses proliferation, and induces apoptosis in rat C6 glioma cells. Neurosci Lett 470: 126-129, 2010.
16. Gong Y, Li Y, Lu Y, Li L, Abdolmaleky H, Blackburn GL and Zhou JR: Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice. Int J Cancer 129: 1042-1052, 2011.
17. Pan TL, Hung YC, Wang PW, Chen ST, Hsu TK, Sintupisut N, Cheng CS and Lyu PC: Functional proteomic and structural insights into molecular targets related to the growth inhibitory effect of tanshinone IIA on HeLa cells. Proteomics 10: 914-929, 2010.
18. Dong X, Dong J and Peng G: Growth-inhibiting and apoptosis-inducing effects of Tanshinone II A on human gastric carcinoma cells. J Huazhong Univ Sci Technolog Med Sci 27: 706-709, 2007.
19. Li JT, Liao ZX, Ping J, Xu D and Wang H: Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies. J Gastroenterol 43: 419-428, 2008. (Pubitemid 351997878)
20. Che XH, Park EJ, Zhao YZ, Kim WH and Sohn DH: Tanshinone IIA induces apoptosis and S phase cell cycle arrest in activated rat hepatic stellate cells. Basic Clin Pharmacol Toxicol 106: 30-37, 2010.
21. Low IC, Kang J, and Pervaiz S: Bcl-2: a prime regulator of mitochondrial redox metabolism in cancer cells. Antioxid Redox Signal: July 12, 2011 (Epub ahead of print).
22. Chen ZX and Pervaiz S: Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells. Cell Death Differ 14: 617-1627, 2007.
23. Chen ZX and Pervaiz S: Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. Cell Death Differ 17: 408-420, 2010.
24. Krishna S, Low IC and Pervaiz S: Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2. Biochem J 435: 545-551, 2011.